SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001060736-23-000007
Filing Date
2023-02-15
Accepted
2023-02-15 16:11:20
Documents
14
Period of Report
2023-02-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sgen-20230215.htm   iXBRL 8-K 35299
2 EX-99.1 ex-9912022q4.htm EX-99.1 120872
6 imagea.jpg GRAPHIC 187351
  Complete submission text file 0001060736-23-000007.txt   566834

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgen-20230215.xsd EX-101.SCH 2001
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgen-20230215_lab.xml EX-101.LAB 24229
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgen-20230215_pre.xml EX-101.PRE 12683
8 EXTRACTED XBRL INSTANCE DOCUMENT sgen-20230215_htm.xml XML 10805
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 23635467
SIC: 2836 Biological Products, (No Diagnostic Substances)